Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (101-110 of 174) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34<sup>+</sup> Selected Allogeneic Hematopoietic Stem Cell TransplantationGunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Blood Advances|July 11, 2019
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionMatthew J Pianko, Sean M Devlin, Eric R Littmann, et al.
Blood|November 8, 2014
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantationDoris M Ponce, Patrick Hilden, Christen Mumaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2016
Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case ForumPere Barba, Linda J Burns, Mark R Litzow, et al.
Bone Marrow Transplantation|April 28, 2022
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplantMaria Sola, Valkal Bhatt, Meighan Palazzo, et al.
American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34<sup>+</sup> Selected Grafts for Allogeneic Hematopoietic Cell TransplantationPere Barba, Ravin Ratan, Christina Cho, et al.
Blood Cancer Journal|May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myelomaBruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood|May 20, 2024
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myelomaOla Landgren, Thomas J Prior, Tara Masterson, et al.
American Journal of Hematology|March 2, 2021
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapyBrian J Ball, Meier Hsu, Sean M Devlin, et al.
Pageof 18

Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34<sup>+</sup> Selected Allogeneic Hematopoietic Stem Cell TransplantationGunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Blood Advances|July 11, 2019
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionMatthew J Pianko, Sean M Devlin, Eric R Littmann, et al.
Blood|November 8, 2014
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantationDoris M Ponce, Patrick Hilden, Christen Mumaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2016
Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case ForumPere Barba, Linda J Burns, Mark R Litzow, et al.
Bone Marrow Transplantation|April 28, 2022
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplantMaria Sola, Valkal Bhatt, Meighan Palazzo, et al.
American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34<sup>+</sup> Selected Grafts for Allogeneic Hematopoietic Cell TransplantationPere Barba, Ravin Ratan, Christina Cho, et al.
Blood Cancer Journal|May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myelomaBruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood|May 20, 2024
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myelomaOla Landgren, Thomas J Prior, Tara Masterson, et al.
American Journal of Hematology|March 2, 2021
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapyBrian J Ball, Meier Hsu, Sean M Devlin, et al.
Pageof 18